Tongsai granule for syndrome of phlegm heat obstructing lung in acute exacerbation of chronic obstructive pulmonary disease: a pilot study

The First Affiliated Hospital of He'nan University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Patients who are diagnosed with moderate to severe AECOPD;
•(2) Patients who meet the Chinese medicine syndrome classification of phlegm heat obstructing lung;
•(3) Patients who are aged 40–80 years;
•(4) Patients who do not participate in other interventional trials in the past month;
•(5) Patients who sign the written informed consent form.

•(1) Patients who are pregnant or lactating;
•(2) Patients who are unable to communicate;
•(3) Patients who have heart failure (NYHA Class IV), severe cardiac arrhythmias,or unstable hemodynamics;
•(4) Patients who have bronchiectasis, active tuberculosis, pneumothorax, pleural effusion, pulmonary thromboembolic, or neuromuscular diseases affecting respiratory movement function;
•(5) Patients who have a history of tumor;
•(6) Patients who have been treated for more than seven days outside the hospital;
•(7) Patients who require invasive mechanical ventilation;
•(8) Patients who have severe liver or kidney disease;
•(9) Patients who require long-term bed rest;
•(10) Patients who have known hypersensitivity to the study medication or some of its ingredients.

发起方

The First Affiliated Hospital of He'nan University of Chinese Medicine